Amends the Internal Revenue Code to provide that the term "taxable vaccine" shall apply to any vaccine against hepatitis A manufactured or produced in the United States or brought into the United States for consumption, use, or warehousing, thus providing that the vaccine excise tax shall apply to such vaccines.
Actions
Apr 8, 2003
Referred to the House Committee on Ways and Means.